Total Return CAGR:-11.46%(TTM)
Over the latest trailing 12-month period, total return cagr is -11.46%. The comparable SPY value is +22.28%. Year-to-date total return is -16.47%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Total Return CAGR averages 0.97% over 3 years and 1.32% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
STE Total Return CAGR Chart
STERIS plc (STE)
STE Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
STE Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 2065.58 | 1725.45 | -340.13 | -16.47% | -16.47% |
| 2025 | 1658.22 | 2065.58 | +407.36 | +24.57% | +24.57% |
| 2024 | 1756.61 | 1658.22 | -98.39 | -5.60% | -5.60% |
| 2023 | 1461.46 | 1756.61 | +295.15 | +20.20% | +20.20% |
| 2022 | 1908.98 | 1461.46 | -447.52 | -23.44% | -23.44% |
| 2021 | 1474.31 | 1908.98 | +434.67 | +29.48% | +29.48% |
| 2020 | 1174.51 | 1474.31 | +299.81 | +25.53% | +25.53% |
| 2019 | 814.99 | 1174.51 | +359.52 | +44.11% | +44.11% |
| 2018 | 659.06 | 814.99 | +155.93 | +23.66% | +23.66% |
| 2017 | 500.38 | 659.06 | +158.68 | +31.71% | +31.71% |
| 2016 | 550.75 | 500.38 | -50.38 | -9.15% | -9.15% |
| 2015 | 467.34 | 550.75 | +83.41 | +17.85% | +17.85% |
| 2014 | 340.63 | 467.34 | +126.71 | +37.20% | +37.20% |
| 2013 | 241.64 | 340.63 | +98.99 | +40.96% | +40.96% |
| 2012 | 202.89 | 241.64 | +38.75 | +19.10% | +19.10% |
| 2011 | 242.98 | 202.89 | -40.09 | -16.50% | -16.50% |
| 2010 | 183.37 | 242.98 | +59.61 | +32.51% | +32.51% |
| 2009 | 154.86 | 183.37 | +28.51 | +18.41% | +18.41% |
| 2008 | 185.26 | 154.86 | -30.40 | -16.41% | -16.41% |
| 2007 | 160.39 | 185.26 | +24.87 | +15.51% | +15.51% |
| 2006 | 158.32 | 160.39 | +2.07 | +1.31% | +1.31% |
| 2005 | 149.37 | 158.32 | +8.95 | +5.99% | +5.99% |
| 2004 | 142.32 | 149.37 | +7.05 | +4.96% | +4.96% |
| 2003 | 152.71 | 142.32 | -10.39 | -6.80% | -6.80% |
| 2002 | 115.05 | 152.71 | +37.66 | +32.73% | +32.73% |
| 2001 | 101.57 | 115.05 | +13.48 | +13.27% | +13.27% |
| 2000 | 64.55 | 101.57 | +37.03 | +57.37% | +57.37% |
| 1999 | 179.09 | 64.55 | -114.55 | -63.96% | -63.96% |
| 1998 | 151.95 | 179.09 | +27.14 | +17.86% | +17.86% |
| 1997 | 136.96 | 151.95 | +14.99 | +10.94% | +10.94% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 1,725 | -4.0% | -10.8% |
| Q1 2026 | 1,797 | -13.9% | +0.2% |
| Q4 2025 | 2,088 | +3.1% | +25.9% |
| Q3 2025 | 2,024 | +4.7% | +3.7% |
| Q2 2025 | 1,934 | +7.8% | +9.7% |
| Q1 2025 | 1,794 | +8.2% | -0.7% |
| Q4 2024 | 1,658 | -15.0% | -5.6% |
| Q3 2024 | 1,951 | +10.7% | +9.3% |
| Q2 2024 | 1,762 | -2.4% | +4.4% |
| Q1 2024 | 1,806 | +2.8% | +19.0% |
| Q4 2023 | 1,756 | -1.6% | +21.7% |
| Q3 2023 | 1,785 | +5.8% | +40.7% |
| Q2 2023 | 1,687 | +11.2% | +3.1% |
| Q1 2023 | 1,517 | +5.2% | -16.9% |
| Q4 2022 | 1,443 | +13.8% | -20.4% |
| Q3 2022 | 1,268 | -22.5% | -23.6% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio